Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996–2002
- 19 September 2003
- journal article
- research article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 18 (7) , 519-524
- https://doi.org/10.1002/hup.528
Abstract
The present study reports on all deaths related to taking ecstasy (alone, or in a polydrug combination) occurring in England and Wales in the time frame August 1996–April 2002. Data presented here are based on all information recorded in the National Programme on Substance Abuse Deaths (np‐SAD) database. The np‐SAD regularly receives all information on drug related deaths in addicts and non addicts from coroners. A total of 202 ecstasy‐related fatalities occurred in the chosen time‐frame, showing a steady increase in the number of deaths each year. The ratio male:female was 4:1 and 3 of 4 victims were younger than 29. In 17% of cases ecstasy was the sole drug implicated in death and in the remaining cases a number of other drugs (mostly alcohol, cocaine, amphetamines and opiates) have been found. According to toxicology results, MDMA accounted for 86% of cases and MDA for 13% of cases; single deaths were associated with MDEA and PMA. This is the largest sample of ecstasy related deaths so far; possible explanations are given for the observed steady increase in ecstasy‐related deaths and a tentative ‘rationale’ for this polypharmacy combination is then proposed. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 21 references indexed in Scilit:
- Ecstasy and Drug Consumption Patterns: A Canadian Rave Population StudyThe Canadian Journal of Psychiatry, 2002
- CYP2D6 deficiency, a factor in ecstasy related deaths?British Journal of Clinical Pharmacology, 2002
- Differences Between Ecstasy-Using and Nonusing Methamphetamine UsersJournal of Psychoactive Drugs, 2002
- Cell‐Mediated Immune Response in MDMA Users After Repeated Dose AdministrationAnnals of the New York Academy of Sciences, 2002
- Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical researchHuman Psychopharmacology: Clinical and Experimental, 2001
- Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problemsPsychopharmacology, 2001
- Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drugJournal of Psychopharmacology, 2001
- Fatal uncertainty: death-rate from use of ecstasy or heroinThe Lancet, 1999
- Hyponatraemia and death after “ecstasy” ingestionThe Medical Journal of Australia, 1997
- Ecstasy and the dance of death.BMJ, 1992